Published in

American Chemical Society, Journal of Medicinal Chemistry, 3(61), p. 1355-1374, 2018

DOI: 10.1021/acs.jmedchem.7b01914

Links

Tools

Export citation

Search in Google Scholar

3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4

Journal article published in 2018 by Qingyun Ren ORCID, Xinchang Liu, Guanghua Yan, Biao Nie, Zhifu Zou, Jing Li, Yunfu Chen, Yu Wei, Jianzhou Huang, Zhonghua Luo, Baohua Gu, Siegfried Goldmann ORCID, Jiancun Zhang, Yingjun Zhang
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO